Closed Solicitation · NATIONAL AERONAUTICS AND SPACE ADMINISTRATION

    TECHNOLOGY TRANSFER OPPORTUNITY: NONINVASIVE THERAPY FOR CARTILAGE REGENERATION (MSC-TOPS-96)

    NATIONAL AERONAUTICS AND SPACE ADMINISTRATION
    Sol. T2P-JSC-00052Special NoticeWASHINGTON, DC
    Closed
    STATUS
    Closed
    closed Aug 13, 2025
    POSTED
    Sep 20, 2024
    Publication date
    NAICS CODE
    927110
    Primary industry classification
    PSC CODE
    9999
    Product & service classification

    AI Summary

    NASA is offering a technology transfer opportunity for a noninvasive therapy aimed at cartilage regeneration, specifically through a pulsed electromagnetic field (PEMF) device developed at the Johnson Space Center. This device addresses cartilage degradation in synovial joints caused by various conditions, providing a pain-free alternative to surgical interventions. The technology is currently at a technology readiness level (TRL) 6, indicating it has been demonstrated in an operational environment. Companies interested in licensing this technology can apply for exclusive or nonexclusive rights, with specific fields of use potentially available. It is important to note that NASA does not provide funding for these licenses. Interested

    Contract details

    Solicitation No.
    T2P-JSC-00052
    Notice Type
    Special Notice
    Posted Date
    September 20, 2024
    Response Deadline
    August 13, 2025
    NAICS Code
    927110AI guide
    PSC / Class Code
    9999
    Contract Code
    8000
    Issuing Office
    NASA HEADQUARTERS
    State
    DC
    ZIP Code
    20546
    AI Product/Service
    product

    Description

    NASA’s Technology Transfer Program solicits inquiries from companies interested in obtaining license rights to commercialize, manufacture and market the following technology. License rights may be issued on an exclusive or nonexclusive basis and may include specific fields of use. NASA provides no funding in conjunction with these potential licenses.

    THE TECHNOLOGY:

    Innovators at NASA Johnson Space Center researching time-variance magnetic field (TVMF) therapies have developed a pulsed electromagnetic field (PEMF) device that can alleviate cartilage degradation in synovial joints by promoting the growth of new cartilage. Joint disorders, whether induced by rheumatism, joint dysplasia, trauma, or surgery, often degrade cartilage and result in intense patient pain. Noninvasive and painless regeneration of a patient’s own tissue offers fewer side-effects than surgical joint replacement or tissue engineering procedures. The PEMF device could simply be wrapped around synovial joints where cartilage-degrading inflammation is located. This pulsed electromagnetic field technology is at a technology readiness level (TRL) 6 (system/sub-system model or prototype demonstration in an operational environment) and the related patent is available for licensing. Please note that NASA does not manufacture products itself for commercial sale.

    To express interest in this opportunity, please submit a license application through NASA’s Automated Technology Licensing Application System (ATLAS) by visiting https://technology.nasa.gov/patent/MSC-TOPS-96

    If you have any questions, please e-mail NASA’s Technology Transfer Program at Agency-Patent-Licensing@mail.nasa.gov with the title of this Technology Transfer Opportunity as listed in this SAM.gov notice and your preferred contact information. For more information about licensing other NASA-developed technologies, please visit the NASA Technology Transfer Portal at https://technology.nasa.gov/

    These responses are provided to members of NASA’s Technology Transfer Program for the purpose of promoting public awareness of NASA-developed technology products, and conducting preliminary market research to determine public interest in and potential for future licensing opportunities. No follow-on procurement is expected to result from responses to this Notice.

    Key dates

    1. September 20, 2024Posted Date
    2. August 13, 2025Proposals / Responses Due

    AI search tags

    Frequently asked questions

    TECHNOLOGY TRANSFER OPPORTUNITY: NONINVASIVE THERAPY FOR CARTILAGE REGENERATION (MSC-TOPS-96) is a federal acquisition solicitation issued by NATIONAL AERONAUTICS AND SPACE ADMINISTRATION. Review the full description, attachments, and submission requirements on SamSearch before the response deadline.

    SamSearch Platform

    Stop searching. Start winning.

    AI-powered intelligence for the right opportunities, the right leads, and the right time.